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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53 S39Purpose: Site-1 protease (S1P) is a proprotein convertase that is
primarily known for processing of latent, endoplasmic reticulum (ER)
membrane-bound transcription factors SREBPs and ATF6 to their free
and active form. SREBPs are involved in cholesterol and fatty acid
homeostasis; ATF6 is involved in ER stress response. Cartilage-
speciﬁc knockout of S1P in mice (S1Pcko) results in poor cartilage
with a drastic decrease of collagen type IIB (Col IIB) in the matrix
and a complete lack of endochondral bone formation. Ultrastructural
analysis of the cartilage shows engorged and fragmented ER
characteristic of ER stress. S1Pcko chondrocytes would be expected to
lack both active SREBPs and ATF6 proteins. The goal of this study is
to identify the requirement of SREBPs- and ATF6-related pathways
for normal Col IIB deposition in the cartilage
Methods: RNAwas extracted from the cartilage of E16.5 S1Pcko and wild
type (WT) littermates followed by genome-wide expression proﬁling
using Illumina MouseWG-6 v2 Expression BeadChip, and differential
gene expression was analyzed by 2-way ANOVA. The expression
proﬁling was further conﬁrmed by qPCR. Col IIB processing in S1Pcko
mice was analyzed by immunoﬂuorescence. Knockout mouse models
of genes down-regulated in S1Pcko chondrocytes were analyzed for Col
IIB deposition. Cartilage-speciﬁc deletion of S1P was also analyzed
temporally in a postnatal S1P ablation model via in situ hybridization
and immunoﬂuorescence to follow the relationship between S1P
ablation and Col IIB entrapment in chondrocytes.
Results: Genome-wide expression proﬁling followed by qPCR analyses
demonstrated that ATF6-directed ER stress response was normal in
S1Pcko mice. However, fatty acid and cholesterol synthesis was down-
regulated in S1Pcko with the largest reduction seen in expression of
stearoyl-CoA desaturase 1 (Scd1) gene. However, Scd1-/- knockout
mice did not display any defects in Col IIB deposition. Double labeled
immunoﬂuorescence analysis demonstrated the retention of Col IIB in
the ER of S1Pcko chondrocytes, but not that of COMP and aggrecan.
Temporal studies with postnatal S1P ablation demonstrated that Col
IIB retention inside the chondrocyte is almost immediate on S1P
ablation, which was followed later by chondrocyte apoptosis. In
double-labeled immunoﬂuorescence studies targeting Col IIB triple
helical domain and the Col II N-propeptide, the WT exhibited signals
from the triple helical domain primarily in the matrix and those from
the N-propeptide inside the cell. In S1Pcko however, signals from the
triple helical domain and the N-propeptide overlapped inside the cell,
suggesting abnormal processing of the Col IIB protein. Western
blotting for the Col II N-proteinase ADAMTS3 demonstrated the
retention of ADAMTS3 in S1Pcko chondrocytes that was not seen in WT
cells
Conclusions: Our studies demonstrated that S1P plays a pivotal role,
direct or indirect, in Col IIB maturation. The retention of Col II
N-terminus and Col IIB triple helical domain along with ADAMTS3 in
S1Pcko chondrocytes indicates a role for S1P in Col IIB processing, in the
absence of which chondrocytes are unable to secrete Col IIB into the
matrix. Even though cholesterol and lipid homeostasis pathways are
down-regulated in S1Pcko, the lack of any bone or cartilage phenotype
in Scd1-/- knockout mice suggests that S1P does not play this role via
SREBP processing. As ATF6-related pathways are not down-regulated
in S1Pcko and ER stress response was secondary to Col IIB retention,
ATF6-related pathways are not the primary cause for Col IIB anomalies.
These data along with the retention of ADAMTS3 in S1Pcko
chondrocytes suggest additional proprotein convertase activities for
S1P, besides transcription factor processing, that are essential for Col
IIB processing and cartilage development.
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INORGANIC POLYPHOSPHATE EXHIBITS ANABOLIC EFFECTS ON
ARTICULAR CARTILAGE
J.-P. St-Pierre, J.N. De Croos, J.S. Theodoropoulos, M. Petrera, P. Sharma,
S. Li, R.M. Pilliar, M.D. Grynpas, R.A. Kandel. CIHR-BioEngineering of
Skeletal Tissues Team, Mount Sinai Hosp. and Univ. of Toronto, Toronto,
ON, Canada
Purpose: Osteoarthritis (OA) is a group of diseases characterized by the
loss of articular cartilage as a result of an imbalance between anabolic
and catabolic processes, as well as tissue calciﬁcation. Current OA
therapies aim to reduce symptoms but do notmodify the progression of
the disease. Inorganic polyphosphate (PP) is a linear polymer of
orthophosphate residues linked by energy-rich phosphoanhydride
bonds. It is found ubiquitously in biological systems from bacteria toanimal cells and is present in relatively large quantities in articular
cartilage and bone. PP is known to inhibit tissue calciﬁcation. The
purpose of this study was to determine if PP treatment would have an
anabolic effect on cartilage. This was evaluated both in vitro and in vivo.
Methods: Articular cartilage was obtained from bovine metacarpal-
phalangeal joints and either maintained in explant culture or used for
chondrocyte isolation. Cells harvested by enzymatic digestion were
seeded on membrane inserts (1x106 cells/insert). The 3D cultures were
maintained under standard tissue culture conditions in the presence or
absence of PP for various times up to 4 weeks. Resulting tissues were
analyzed for DNA, glycosaminoglycan (GAG) and collagen synthesis and
accumulation, gene expression and exopolyphosphatase activity. Full
thickness cartilage explants were treated similarly but harvested after 1
week. To evaluate the effect of PP on the progression of OA, left-medial
menisectomy was performed on the knee of 20 male Hartley guinea
pigs (3 months of age). Starting the day following surgery, the animals
received biweekly intra-articular injections (100ml) of either: 1) 4mM
PP in PBS, or 2) PBS alone (10 animals/ condition). After 2 months, the
animals were sacriﬁced and the joints, following decalciﬁcation and
parafﬁn embedding, were evaluated histologically using the OARSI
guinea pig grading scale.
Results: PP stimulated GAG and collagen accumulation by chondrocytes
in a concentration and chain length dependent manner. The optimal PP
chain length for matrix accumulation was 45 phosphate units. This
effect of PP on matrix accumulation was reversible as exopolyphos-
phatases were produced by chondrocytes that can cleave the end
phosphate of PP chains. Similar concentrations (on a phosphate basis) of
orthophosphate and inorganic pyrophosphate had no effect on matrix
accumulation by chondrocytes. Collagen type II, aggrecan and sox9 gene
expression were not altered by the PP treatment but proteoglycan and
collagen synthesis were both signiﬁcantly increased by the treatment. A
time course study demonstrated increased DNA content in cultures
treated with PP with time, albeit at a decreased rate compared to
untreated cultures. Cartilage explants responded similarly to PP treat-
ment as the chondrocyte cultures. Intra-articular injections of PP were
chondroprotective as the histological OA score was signiﬁcantly
decreased in the treated OA guinea pig model compared to that of
animals treated with the PBS carrier (PP treated: 7.4  3.09; Carrier:
16.9  3.55; p<0.05; Mann-Whitney test; n¼10).
Conclusions: PP was shown to be chondroprotective in a menisectom-
ized guinea pig model of OA. In vitro studies suggest this effect is
mediated at least in part by stimulating matrix production by chon-
drocytes. Further study is ongoing to optimize PP delivery in vivo.
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SECOND GENERATION CHARACTERIZED CHONDROCYTE
IMPLANTATION FOR THE TREATMENT OF CARTILAGE LESIONS IN
THE KNEE
A.A. Dhollander, P.C. Verdonk, S. Lambrecht, R. Verdonk, D. Elewaut,
G. Verbruggen, F. Almqvist. Ghent Univ., Ghent, Belgium
Purpose: To evaluate short-term clinical and MRI outcome of the
second generation characterized chondrocyte implantation (CCI) for the
treatment of cartilage defects in the knee.
Methods: Thirty-two patients aged 15-51 years with sin- gle Interna-
tional Cartilage Repair Society (ICRS) grade III/ IV symptomatic cartilage
defects of different locations in the knee were treated with CCI using
a synthetic collagen I/III membrane to cover the defect. Clinical outcome
was measured over 36 months by the Knee injury and Osteoarthritis
Outcome Score (KOOS) and Visual Analogue Scale (VAS) for pain. Serial
magnetic resonance imaging (MRI) scans of 22 patients were scored
using the original and modiﬁed Magnetic resonance Observation of
Cartilage Repair Tissue (MOCART) system.
Results: The patients included in this study showed a signiﬁcant
gradual clinical improvement after CCI. The MRI ﬁndings of this pilot
study were considered to be promising. No signs of deterioration were
observed. A complete or hypertrophic ﬁlling was observed in 76.5% of
the cases at 24 months of follow-up. No preventive effect of an avital
membrane on the occurrence of hypertrophic repair tissue was
observed on MRI. Three failures were observed among the 32 patients
until now (9.4%).
Conclusions: This investigation provided useful information on the
efﬁcacy of this treatment. The short-term clinical and MRI outcome are
promising. Large-scale and long-term trials are mandatory to conﬁrm
the results and the reliability of this procedure.
